Feb 19, 2020Inflection Biosciences Announces Appointment of Shaun McNulty, Ph.D., as Chief Scientific Officer.Dublin, Ireland, February 19th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
Feb 6, 2020Inflection Biosciences Announces Appointment of Murray Yule, M.D., Ph.D., as Chief Medical Officer(06 Feb 2020) Dublin, Ireland, February 6th, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the...
Jan 31, 2020Inflection Biosciences to present at BIO CEO & Investor Conference 2020.Dublin, Ireland, January 31, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
Nov 26, 2019Inflection Biosciences Selected as Tech Tour Contest Finalist for 2019Dublin, Ireland, November 26, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
Oct 30, 2019Inflection Biosciences Announces Passing of Co-Founder and Board Member John ScanlanDublin, Ireland, October 30, 2019 – Inflection Biosciences Ltd today announced that John Scanlan, a co-founder and a member of its Board...
Sep 9, 2019Inflection Biosciences Announces Pre-clinical Data to be Presented at IASLC 2019 World Conference.Dublin, Ireland, September 9th, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...